| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/18/1997 | US5604221 Treating congestive heart failure, irritable bowel syndrome |
| 02/18/1997 | US5604103 Kit for detection of clinical marker in kidney stone disease |
| 02/18/1997 | US5603959 Non-steroidal anti-inflammatory drug linked with unsaturated fatty acid or alcohol; cytoprotective agents, side effect reduction |
| 02/17/1997 | CA2183307A1 Endothelin receptor antagonists |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/13/1997 | WO1997004802A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | WO1997004781A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004773A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004772A1 Endothelin receptor antagonists |
| 02/13/1997 | DE19529612A1 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate Sulfonyl or sulfinyl derivatives benzoylguanidine |
| 02/13/1997 | DE19529102A1 Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen Use of PDE inhibitors in the treatment of urinary bladder diseases |
| 02/13/1997 | CA2228296A1 Endothelin receptor antagonists |
| 02/13/1997 | CA2228293A1 Endothelin receptor antagonists |
| 02/13/1997 | CA2228176A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/12/1997 | EP0757982A1 Biphenylic compounds, process for their preparations and intermediates for this process, their use as 5-alpha-reductase inhibitors and pharmaceutical compositions containing them |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757670A1 Benzamide derivatives as vasopressin antagonists |
| 02/12/1997 | EP0757669A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142816A Crystalline, polymorphic form of (S,S,S)-n-(1-|2-carboxy-3-(n2-mesyllysylamino)propyl¨-1-cyclopenlylcarbonyl)tyrosine |
| 02/12/1997 | CN1142394A Oral liquid of purslane speedwell and preparation thereof |
| 02/11/1997 | US5602169 Useful in reducing neuronal damage during ischemic stroke |
| 02/11/1997 | US5602137 Treating cardiovascular or circulatory disorders |
| 02/11/1997 | US5602136 Cardiovascular and nervous system disorders |
| 02/11/1997 | US5602133 Treatment of polycystic ovary syndrome |
| 02/11/1997 | US5602132 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 02/11/1997 | US5602116 Administering vitamin d analog |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601804 Antiplaque agent |
| 02/11/1997 | CA2054212C Method for polymerization of epoxide compounds |
| 02/11/1997 | CA1338906C 11 beta-substituted progesterone analogs |
| 02/06/1997 | WO1997003675A1 Use of cgmp-phosphodiesterase inhibitors to treat impotence |
| 02/05/1997 | EP0757039A1 Endothelin receptor antagonists |
| 02/05/1997 | EP0756482A1 Transdermal delivery of alpha adrenoceptor blocking agents |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/04/1997 | US5599937 Heteroaromatic quinuclidinenes, their use and preparation |
| 02/04/1997 | US5599830 Sulphorous derivatives of imidazole and their use as medicaments |
| 02/04/1997 | US5599811 Phenyl or dioxyphenyl substituents; drugs |
| 02/04/1997 | US5599810 Furo- and thieno[4,3,2-ef][3]benzazepines useful as alpha adrenergic receptor antagonists |
| 02/04/1997 | US5599796 Treatment of urogenital cancer with boron neutron capture therapy |
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/03/1997 | CA2182469A1 Endothelin-receptor-antagonists |
| 01/30/1997 | WO1997003071A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 01/30/1997 | WO1997003067A1 Piperazine derivatives as therapeutic agents |
| 01/30/1997 | WO1997003066A1 Substituted benzolactam compounds as substance p antagonists |
| 01/30/1997 | WO1997002835A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | WO1997002833A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002826A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 01/30/1997 | CA2226553A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | CA2226392A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | CA2223472A1 Therapeutic agents |
| 01/29/1997 | EP0755934A1 Endothelin receptor antagonists |
| 01/29/1997 | EP0755931A1 Dihydropyridine and pyridine derivatives and process for their preparation |
| 01/29/1997 | EP0755919A2 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them |
| 01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
| 01/29/1997 | EP0755392A1 Alpha1c adrenergic receptor antagonists |
| 01/29/1997 | EP0755382A1 Quinolone derivative for treatment of urinary incontinence |
| 01/29/1997 | EP0723453A4 Method of treating reproductive disorders |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141590A Agent for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 01/29/1997 | CN1141298A Pyrimidine-fused heterocyclic compound anti-cancer agents |
| 01/29/1997 | CN1141297A Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 01/29/1997 | CA2182156A1 Endothelin-receptor-antagonists |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597823 Treating benign prostatic hyperplasia |
| 01/28/1997 | US5597815 Prevention of hyperphosphatemia in kidney disorder patients |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
| 01/23/1997 | WO1997002032A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/23/1997 | CA2224451A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754054A1 Antirestenosis protein |
| 01/22/1997 | EP0754043A1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0754040A1 Rapamycin derivatives |
| 01/22/1997 | EP0461200B1 Modified forms of reproductive hormones |
| 01/22/1997 | CN1141043A Non-peptide tachykinin receptor antagonists |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/21/1997 | US5596004 Methods of inhibiting male infertility |
| 01/21/1997 | US5595995 Anticarcinogenic agents |
| 01/21/1997 | US5595970 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors |
| 01/21/1997 | CA2028235C Condensed purine derivatives |
| 01/21/1997 | CA2022682C Cycloalkylene azoles, processes for their production and use, and pharmaceutical preparations obtained therefrom |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752871A1 Adhesion inhibiting composition |
| 01/15/1997 | EP0752854A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 01/15/1997 | CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase |
| 01/15/1997 | CN1140167A Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromanes |
| 01/14/1997 | US5594032 Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
| 01/14/1997 | US5594023 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present |
| 01/14/1997 | US5594019 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles |
| 01/14/1997 | US5593987 Methods of inhibiting breast disorders |
| 01/09/1997 | WO1997000894A1 Compounds with growth hormone releasing properties |